Deal Details

Acquisition of Tecomet, Inc.

---

Summary

About

Charlesbank Capital Partners, LLC (“Charlesbank”) recently completed the acquisition of Tecomet, Inc. (“Tecomet” or the “Company”), a portfolio company of Genstar Capital, LLC (“Genstar”). Terms of the transaction were not disclosed.

Charlesbank Capital Partners, LLC is a middle-market private equity investment firm managing more than $3.4 billion of capital. Charlesbank focuses on management-led buyouts and growth capital financings, typically of companies with enterprise values between $150 million and $1.5 billion, and also engages in opportunistic credit investments. Charlesbank seeks to partner with strong management teams to build companies with sustainable competitive advantage and excellent prospects for growth. Charlesbank is headquartered in Boston, Massachusetts.

Tecomet is a leading global manufacturer of high precision products. The Company manufactures orthopedic implants, surgical instruments, trauma plates and photochemical etched products for medical device customers. Tecomet also manufactures products used in aircraft engines, missile and satellite propulsion systems, vision systems and infrared applications for the aerospace and defense industry. The transaction marks Charlesbank’s second acquisition of the Company, each time in partnership with management. Tecomet is headquartered in Wilmington, Massachusetts.

Genstar Capital, LLC is a leading private equity firm that has been actively investing in high quality companies for more than 25 years. Genstar works in partnership with its management teams and its network of strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar manages funds with total capital commitments of approximately $9 billion and targets investments focused on targeted segments of the industrial technology, healthcare, financial services and software industries. Genstar is headquartered in San Francisco, California.

---

CONTACT US TO LEARN MORE